Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01107314 · ClinicalTrials.gov registry record
Vasopressin Deficiency in Hemorrhagic Shock
A clinical trial of Body Response to Trauma, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- 81
- Enrollment target
- 1
- Study location
NCT01107314: Completed study of Body Response to Trauma, sponsored by The University of Texas Health Science Center at San Antonio.
NCT01107314 is a study of Body Response to Trauma that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 81 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01107314, a study of Body Response to Trauma, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study we hope to delineate the typical vasoactive mediator response of trauma patients to shock. We plan to assess serum levels of vasopressin and also catecholamines, angiotensin, and cortisol during resuscitation of trauma patients to delineate high risk populations for vasopressin deficiency.
Conditions Studied
Interventions
- OTHER Phlebotomy
Study Locations (1)
Texas
- UTHSCSA - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-04-30 |
What the finished NCT01107314 record still lists
NCT01107314 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 81 participants, a relatively small participant target.
The record links to 1 condition, with Body Response to Trauma appearing as the primary indexed condition, and to 1 intervention - of which Phlebotomy is the first listed.
NCT01107314 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01107314 about?
NCT01107314 is a clinical study titled "Vasopressin Deficiency in Hemorrhagic Shock". In this study we hope to delineate the typical vasoactive mediator response of trauma patients to shock. We plan to assess serum levels of vasopressin and also catecholamines, angiotensin, and cortisol during resuscitation of trauma patients to delineate high risk populations for vasopressin deficie...
What is the current status of trial NCT01107314?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2010-02. Estimated completion is 2011-04-30.
What conditions does trial NCT01107314 study?
This clinical trial studies the following conditions: Body Response to Trauma.
What interventions are being tested in trial NCT01107314?
The interventions under investigation include: Phlebotomy (OTHER).
Who is sponsoring clinical trial NCT01107314?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01107314 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia